Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea
US11911370B1 · kind B1 · utility
0Cited by
96References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 19, 2023 |
| Grant date | Feb 27, 2024 |
| Priority date | — |
| Expiry date | Oct 19, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are low impurity compositions comprising a compound represented by Formula (I): which are useful in the treatment of disorders related to the activity of the c-KIT and PDGFRα kinases, and oncogenic forms thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.